These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6533297)

  • 1. Theorems and implications of a model independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. I. Derivations and theoretical analysis.
    Veng-Pedersen P
    J Pharmacokinet Biopharm; 1984 Dec; 12(6):627-48. PubMed ID: 6533297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. II. Clearance concepts applied to the evaluation of distribution kinetics.
    Gillespie WR; Veng-Pedersen P
    J Pharmacokinet Biopharm; 1985 Aug; 13(4):441-51. PubMed ID: 4087171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. IV. Exact relationship between the terminal log-linear slope parameter beta and drug clearance.
    Veng-Pedersen P; Gillespie WR
    J Pharmacokinet Biopharm; 1987 Jun; 15(3):305-25. PubMed ID: 3668806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel method of calculating absolute bioavailability in nonlinear pharmacokinetics.
    Veng-Pedersen P
    J Pharm Sci; 1985 Jan; 74(1):90-3. PubMed ID: 3981428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Model-independent steady-state plasma level predictions in autonomic nonlinear pharmacokinetics I: Derivation and theoretical analysis.
    Veng-Pedersen P
    J Pharm Sci; 1984 Jun; 73(6):761-5. PubMed ID: 6737260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic evaluation of nonlinear drug elimination by a disposition decomposition analysis. Application to the analysis of the nonlinear elimination kinetics of erythropoietin in adult humans.
    Veng-Pedersen P; Widness JA; Pereira LM; Peters C; Schmidt RL; Lowe LS
    J Pharm Sci; 1995 Jun; 84(6):760-7. PubMed ID: 7562419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug absorption evaluation in the presence of changes in clearance: an algorithm and computer program for deconvolution with exact clearance correction.
    Veng-Pedersen P
    Biopharm Drug Dispos; 1987; 8(2):185-203. PubMed ID: 3593898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mean residence times and distribution volumes for drugs undergoing linear reversible metabolism and tissue distribution and linear or nonlinear elimination from the central compartments.
    Cheng HY; Jusko WJ
    Pharm Res; 1991 Apr; 8(4):508-11. PubMed ID: 1871048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stochastic interpretation of linear pharmacokinetics: a linear system analysis approach.
    Veng-Pedersen P
    J Pharm Sci; 1991 Jul; 80(7):621-31. PubMed ID: 1941557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. III. Peripheral bioavailability and distribution time concepts applied to the evaluation of distribution kinetics.
    Veng-Pedersen P; Gillespie WR
    J Pharmacokinet Biopharm; 1987 Jun; 15(3):281-304. PubMed ID: 3668805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nonlinear physiologic pharmacokinetic model: I. Steady-state.
    Wagner JG; Szpunar GJ; Ferry JJ
    J Pharmacokinet Biopharm; 1985 Feb; 13(1):73-92. PubMed ID: 4020623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A technique for calculating the mean time for equilibration of drug distribution using minimal structural assumptions.
    Bailey JM
    J Pharmacokinet Biopharm; 1994 Apr; 22(2):157-64. PubMed ID: 7815311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. System approaches in pharmacokinetics: II. Applications.
    Veng-Pedersen P
    J Clin Pharmacol; 1988 Feb; 28(2):97-104. PubMed ID: 3283181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation of Laplace transform for the general disposition deconvolution equation in drug metabolism kinetics.
    Popović J
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):409-11. PubMed ID: 10445406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theorems on log-convex disposition curves in drug and tracer kinetics.
    Weiss M
    J Theor Biol; 1985 Oct; 116(3):355-68. PubMed ID: 4058025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'MacDope': a simulation of drug disposition in the human body: applications in clinical pharmacokinetics.
    Bloch R; Sweeney G; Ahmed K; Dickinson CJ; Ingram D
    Br J Clin Pharmacol; 1980 Dec; 10(6):591-602. PubMed ID: 7470372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling of drug disposition kinetics in in vitro intestinal absorption cell models.
    Heikkinen AT; Korjamo T; Mönkkönen J
    Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):180-8. PubMed ID: 20030630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noncompartmentally-based pharmacokinetic modeling.
    Veng-Pedersen P
    Adv Drug Deliv Rev; 2001 Jun; 48(2-3):265-300. PubMed ID: 11369086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A general model of metabolite kinetics following intravenous and oral administration of the parent drug.
    Weiss M
    Biopharm Drug Dispos; 1988; 9(2):159-76. PubMed ID: 3370305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General pharmacokinetic equations for linear mammillary models with drug absorption into peripheral compartments.
    Vaughan DP; Mallard DJ; Trainor A; Mitchard M
    Eur J Clin Pharmacol; 1975 Feb; 8(2):141-8. PubMed ID: 1233210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.